A retrospective, non-randomized, clinical review on the effect of single-dose biosimilar Razumab injection in diabetic macular edema

Journal Title: International Journal of Experimental Research and Review - Year 2023, Vol 32, Issue 3

Abstract

Diabetic macular edema (DME) is one of the microvascular complications of diabetes and also coexists with diabetic retinopathy. The present study aims to investigate the effectiveness of single-dose biosimilar Razumab injection in diabetic macular edema. In this retrospective, non-randomized, clinical review on patients (n=50), 50 eyes with diabetic macular edema were selected and treated with a single dose of 2.3mg/0.23mL Razumab injection intravitreally. Visual acuity (VA) and macular thickness (MT), were evaluated for a period of up to 45 days after injecting biosimilar Razumab and were used to assess the effectiveness after treatment for 45 days. The results of the study showed that there was a significant increase in visual acuity and a marked reduction in macular thickness and the intraocular pressure (IOP) and anterior segment (AS) examination reverted to normal after the injection (Day 45). This study concludes that a single dose of biosimilar Razumab injection was effective in improving visual acuity and reducing macular thickness with no ocular concerns in diabetic macular edema patients.

Authors and Affiliations

Arul Balasubramanian, Jeyaprakash Balasubramanian, Atchaya Pugazhenthi, Chandru Balasivaraman, Divya Murugadass, Kothai Ramalingam

Keywords

Related Articles

Development and Validation of RP-HPLC Method for Estimation of Ticagrelor in Pharmaceutical Dosage Form and Force degradation study

Ticagrelor is a selective Adenosine diphosphate (ADP)-receptor antagonist which is prescribed in the form of tablets and acts as an oral antiplatelet for the prevention of further thrombotic events in patients with Acute...

Real-Time Face Recognition System with Enhanced Security Features using Deep Learning

Identification of people and mask detection has long been a captivating topic, in terms of research and business. This topic has received increasing attention in recent phases due to the speedy advancement of Artificial...

The performance analysis of Hydraulic Ram Pump: Influence of specific parameters and validation with Comsol-Multiphysics

Both energy and environmental conservation have been major issues in today’s world. Conventional pumping devices use a huge amount of energy. This gave rise to interest in alternate pumping devices like hydraulic ram pum...

MCIP: Mining Crop Image Data On pysparkdataframe Using Feature Selection and Cluster Based Techniques

Crop-related problems such as pests and diseases in India lead to yearly losses exceeding $500 billion. Leaf blight is identified as the principal factor responsible for the substantial financial losses amounting to $500...

Prevention of VM Timing side-channel attack in a cloud environment using randomized timing approach in AES – 128

The term "cloud computing" refers to the delivery of various computer services to users via the Internet. These services include servers, storage, databases, networking, software, and analytics. The ability for businesse...

Download PDF file
  • EP ID EP720648
  • DOI 10.52756/ijerr.2023.v32.010
  • Views 35
  • Downloads 0

How To Cite

Arul Balasubramanian, Jeyaprakash Balasubramanian, Atchaya Pugazhenthi, Chandru Balasivaraman, Divya Murugadass, Kothai Ramalingam (2023). A retrospective, non-randomized, clinical review on the effect of single-dose biosimilar Razumab injection in diabetic macular edema. International Journal of Experimental Research and Review, 32(3), -. https://europub.co.uk/articles/-A-720648